CompanyDrug

Gilead and MSD Report Positive Interim Data for Once-Weekly HIV Treatment in Phase II Trial

CompanyDeals

Gilead and Merus Form Strategic Oncology Alliance to Develop Trispecific T-Cell Engagers

CompanyDrug

Henlius Biotech’s HER2 Targeting Biosimilar Secures Thai and Philippine Approvals

CompanyDeals

Lee’s Pharmaceutical Secures Malaysian Distribution for Generic Glaucoma Treatment

Company

Sino Medical Sciences Gains Pakistani Nod for SC HONKYTONK and NC ROCKSTAR Catheters

CompanyDrug

Duality Biologics’ DB-1303 on Track for Breakthrough Designation for HER2+ Endometrial Cancer

CompanyDeals

Apeloa Pharmaceutical and ZhenGe Biotech Join Forces to Create Comprehensive ADC Platform

CompanyDeals

ClouDr Inks Deal with CR Sanjiu to Boost Hospital Sales of Cardiovascular Medicine

Company

Lundbeck A/S Posts 8.2% YOY Revenue Growth in 2023 with Strong Performance Across Key Therapies

CompanyDrug

Formosa Pharmaceuticals Secures FDA Nod for New Steroidal Eye Drug, Set to Launch via Eyenovia

CompanyDeals

MGI Tech Lands Eurofins Genomics Deal for T20 Ultra-High Throughput Sequencer in Europe

CompanyDrug

Bayer Posts 1.2% YOY Sales Decline in 2023 with Pharmaceuticals and Consumer Health Segment Updates